Ultrasensitive quantification of plasma biomarkers is shaping the future of care for Alzheimer’s disease
…of plasma biomarkers in AD and the value that these easily-accessible targets can bring to clinical trials, drug development and patient care. Many of these and other recent studies in…
read more